Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn's disease: unexpected results of a randomised, double-blind placebo …
W Hueber, BE Sands, S Lewitzky… - Gut, 2012 - gut.bmj.com
Objective The authors tested whether the anti-interleukin (IL)-17A monoclonal antibody
secukinumab was safe and effective for the treatment of active Crohn's disease. Design In a …
secukinumab was safe and effective for the treatment of active Crohn's disease. Design In a …
[CITATION][C] Secukinumab in Crohn's Disease Study Group. Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn's disease …
W Hueber, BE Sands, S Lewitzky… - Gut, 2012